Future developments may include: Broader Clinical Trials Researchers are investigating how GLP-1 medications may benefit individuals without diabetes but with high cardiovascular risk, potentially leading to expanded FDA approvals for heart disease prevention
For example, in June 2025, Connecticut Attorney General released a statement warning businesses of allegedly or potentially unfair and deceptive conduct related to compounding of GLP-1 medications
Your condition may require ongoing monitoring or further treatment
The mechanisms by which SPARC affects bone formation, maintenance, and repair might occur through multiple pathways, including the regulation of procollagen processing and assembly in the bone matrix, cross-linking, mineralization, and/or osteoblast/osteoclast differentiation and activity [25]
For this reason, its important to start your weight loss journey with qualified healthcare professionals